---  
layout: startup_page  
title: "Aeovian Pharmaceuticals"  
id: "aeovian.com"  
permalink: "/aeovianpharmaceuticalsaeovian.com03282024/"  
website: "https://www.aeovian.com/"  
funding_round: ""  
funding_amount: "$50M"  
investors: "Hevolution, Apollo Health Ventures, Sofinnova Investments, venBio, Evotec, b2venture"  
about: "Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel, highly selective therapeutics that inhibit the mTORC1 pathway. Their lead candidate, AV078, is a first-in-class mTORC1 inhibitor for treating seizures associated with Tuberous Sclerosis Complex (TSC). The company aims to address unmet medical needs in rare neurological and age-related diseases."  
markets: "Biotechnology, Pharmaceuticals, Neurology, Biopharma, Health Care"  
hq: "Berkeley, California, United States"  
founded_year: "2012"  
linkedin: "https://www.linkedin.com/company/aeovian-pharmaceuticals"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/aeonian-pharmaceuticals"  
pitchbook: ""  

date_display: "28-Mar-2024"  
date: "2024-03-28"

# SEO Optimization  
meta_title: "Aeovian Pharmaceuticals -  Funding ($50M)"  
meta_description: "Aeovian Pharmaceuticals, Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel, highly selective therapeutics that inhibit the mTORC1 pathway...."  
meta_keywords: "Aeovian Pharmaceuticals, Biotechnology, Pharmaceuticals, Neurology, Biopharma, Health Care,  funding"  
canonical_url: "https://startup.projectstartups.com/aeovianpharmaceuticalsaeovian.com03282024/"  
---